### ü´Å Pulm/CC: Diagnosis of Asthma  

#### ‚úÖ True Statements  
1. Diagnosis of **asthma** requires confirmation of **reversible airflow obstruction**, not just symptoms and examination.  
2. Confirmation of reversible airflow obstruction can be obtained by **spirometry measuring FEV‚ÇÅ, FVC, and the FEV‚ÇÅ/FVC ratio** or by **serial home peak expiratory flow rates**.  
3. An increase in **FEV‚ÇÅ or FVC of ‚â•10%** from baseline after bronchodilator therapy, or **peak flow fluctuations ‚â•20%**, supports the diagnosis of asthma.  
4. If airflow obstruction is not present during initial evaluation, **bronchial challenge testing** is indicated.  
5. A **positive bronchial challenge test** confirms bronchial hyperreactivity but does not confirm asthma; clinical correlation with symptoms is required.  
6. A **negative bronchial challenge test** makes the diagnosis of asthma unlikely.  
7. **Short-acting Œ≤‚ÇÇ-agonist therapy** alone for mild asthma increases the risk for serious exacerbations; all patients with asthma should be treated with an **inhaled glucocorticoid** or **inhaled glucocorticoid‚Äìformoterol**.  
8. **Fractional exhaled nitric oxide testing** is limited by sensitivity and specificity and should not be used alone to diagnose asthma.  
9. **Low-dose budesonide‚Äìformoterol** is appropriate for mild asthma only once the diagnosis is confirmed.  
10. **Key Point:** Diagnosis of asthma requires confirmation of reversible airflow obstruction by spirometry or bronchial challenge testing.  

#### üí¨ Extra(s)  
2. Home peak expiratory flow testing can be used when in-office spirometry is not available.  
3. Some laboratories still use older bronchodilator response thresholds (‚â•12% and ‚â•200 mL improvement in FEV‚ÇÅ).  
8. Fractional exhaled nitric oxide testing may have a role as adjunctive testing or when spirometry cannot be performed.  

#### üìö Reference  
Aaron SD, Vandemheen KL, FitzGerald JM, et al; Canadian Respiratory Research Network. Reevaluation of diagnosis in adults with physician-diagnosed asthma. *JAMA*. 2017;317:269-79. PMID: 28114551 doi:10.1001/jama.2016.19627  

#### üè∑Ô∏è Tags  
#PulmCC #Asthma #Diagnosis #Spirometry #BronchialChallenge #AmbulatoryCare  

#### üÜî Question ID  
PMMCQ24037  

#### üïí Last Updated  
February 2025  

---  

#### üìñ Related Text  
MKSAP: Pulmonary Medicine, Airways Disease, Asthma, Symptoms and Clinical Evaluation of Asthma  

---  

### üìò Related Text Derivations  

#### ‚úÖ True Statements  
1. Common asthma symptoms include **cough, wheezing, chest tightness, and dyspnea**, often intermittent and triggered by allergens, infections, dust, fumes, or exercise.  
2. **Asthma symptoms** often worsen in the **evening and early morning** and are commonly triggered by **viral respiratory infections**.  
3. **Symptom variability** (improvement and worsening over time) is a key diagnostic feature of asthma.  
4. History should assess **smoking, pets, and environmental exposures** known to cause bronchial hyperreactivity.  
5. **Nasal polyps, aspirin sensitivity, and wheezing** constitute the "asthmatic triad."  
6. Physical exam in asthma may show **wheezing, reduced airflow, or prolonged expiration**, but findings may be normal when patients are asymptomatic.  
7. Reversible airflow obstruction is confirmed by **spirometry (FEV‚ÇÅ, FVC, FEV‚ÇÅ/FVC ratio)** or **serial peak flow testing**.  
8. **Bronchodilator response** is significant if **postbronchodilator FEV‚ÇÅ or FVC increases >10% predicted** (2021 ATS/ERS standard); older thresholds are **‚â•12% and ‚â•200 mL**.  
9. If spirometry is normal, **bronchial challenge testing** with methacholine, exercise, or mannitol is indicated.  
10. A **negative bronchial challenge test** makes asthma unlikely, while a positive test indicates bronchial hyperreactivity that requires clinical correlation.  
11. **Fractional exhaled nitric oxide (FeNO) testing** is conditionally recommended as an adjunct in asthma evaluation for patients ‚â•5 years old.  
12. FeNO may be helpful when spirometry cannot be performed, diagnosis is uncertain, or to guide treatment decisions in persistent allergic asthma.  
13. **Chest radiography** is useful to rule out alternative diagnoses such as **COPD, heart failure, parenchymal lung disease, central airway obstruction, and bronchiectasis**.  

#### üí¨ Extra(s)  
1. Environmental triggers include allergens, dust, fumes, and exercise.  
5. The "asthmatic triad" is also called **Samter‚Äôs triad**.  
11. FeNO testing is suggested by the American Thoracic Society but is not a substitute for standard evaluation.  

#### üè∑Ô∏è Related Text Tags  
#PulmCC #Asthma #Symptoms #ClinicalEvaluation #BronchialChallenge #FeNO #Spirometry #ChestRadiography  
